Clyde W. Yancy

5 ta ish

Association of Chartered Certified Accountants

1. 2013 ACCF/AHA Guideline for the Management of Heart Failure

   Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt +21

   Maqola20136 iqtibos

   ABIABI:AkademIndex/2026.other.375123

2. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

   Biykem Bozkurt, David Aguilar, Anita Deswal +9

   Sharh maqola20164 iqtibos

   ABIABI:AkademIndex/2026.other.295818

3. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

   Sheryl L. Chow, Alan S. Maisel, Inder S. Anand +11

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.474563

4. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

   Bernard J. Gersh, Barry J. Maron, Robert O. Bonow +11

   Maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.633026

5. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

   Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt +14

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.684715